ZA909085B - Treatment of depression - Google Patents

Treatment of depression

Info

Publication number
ZA909085B
ZA909085B ZA909085A ZA909085A ZA909085B ZA 909085 B ZA909085 B ZA 909085B ZA 909085 A ZA909085 A ZA 909085A ZA 909085 A ZA909085 A ZA 909085A ZA 909085 B ZA909085 B ZA 909085B
Authority
ZA
South Africa
Prior art keywords
depression
treatment
Prior art date
Application number
ZA909085A
Other languages
English (en)
Inventor
Karen Ann Scappaticci
Ann Scappaticci Karen
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA909085B publication Critical patent/ZA909085B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA909085A 1989-11-14 1990-11-13 Treatment of depression ZA909085B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07436405 US5011841B1 (en) 1989-11-14 1989-11-14 Treatment of depression

Publications (1)

Publication Number Publication Date
ZA909085B true ZA909085B (en) 1992-06-24

Family

ID=23732262

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA909085A ZA909085B (en) 1989-11-14 1990-11-13 Treatment of depression

Country Status (12)

Country Link
US (1) US5011841B1 (pt)
EP (1) EP0437026A3 (pt)
JP (1) JPH03170475A (pt)
KR (1) KR930007252B1 (pt)
AU (1) AU619420B2 (pt)
CA (1) CA2028514C (pt)
HU (1) HUT55633A (pt)
IE (1) IE904084A1 (pt)
MY (1) MY104521A (pt)
NZ (1) NZ236055A (pt)
PT (1) PT95857A (pt)
ZA (1) ZA909085B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330762A (en) * 1992-02-27 1994-07-19 Alza Corporation Tandospiaine antidepressive therapy
US5185158A (en) * 1992-02-27 1993-02-09 Alza Corporation Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same
US5246711A (en) * 1992-02-27 1993-09-21 Alza Corporation Dosage form for treating dysthymia
US5858407A (en) * 1992-02-27 1999-01-12 Alza Corporation Method for administering tandospirone
US5688518A (en) * 1992-02-27 1997-11-18 Alza Corporation Antidepressive therapy
US5246710A (en) * 1992-02-27 1993-09-21 Alza Corporation Dosage form for treating cyclothymia
HUP0204050A3 (en) * 2000-01-19 2004-09-28 Akzo Nobel Nv Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone
US20040002500A1 (en) * 2002-06-28 2004-01-01 Fabre Kramer Pharmaceutical, Inc. Methods for treating attention deficit disorder
EP2601187A1 (en) * 2010-08-05 2013-06-12 Conrig Pharma ApS Deuterated tandospirone derivatives as 5-ht1a receptor agonists
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507303A (en) * 1981-12-22 1985-03-26 Sumitomo Chemical Company, Limited Succinimide derivatives, compositions and method of use
US4771053A (en) * 1987-03-02 1988-09-13 Bristol-Myers Company Method for alleviation of primary depressive disorders
US4855430A (en) * 1987-11-12 1989-08-08 American Home Products Corporation Polycyclicamine with psychotropic activity

Also Published As

Publication number Publication date
EP0437026A3 (en) 1991-10-02
PT95857A (pt) 1991-09-13
KR910009267A (ko) 1991-06-28
HU907135D0 (en) 1991-05-28
AU6660090A (en) 1991-08-01
JPH03170475A (ja) 1991-07-24
NZ236055A (en) 1997-03-24
EP0437026A2 (en) 1991-07-17
HUT55633A (en) 1991-06-28
KR930007252B1 (ko) 1993-08-04
US5011841B1 (en) 1994-09-06
US5011841A (en) 1991-04-30
MY104521A (en) 1994-04-30
CA2028514C (en) 1995-02-07
IE904084A1 (en) 1991-05-22
AU619420B2 (en) 1992-01-23
CA2028514A1 (en) 1991-05-15

Similar Documents

Publication Publication Date Title
GB8921123D0 (en) Treatment of ards
US5011841B1 (en) Treatment of depression
GB8921326D0 (en) Novel treatment
GB8918297D0 (en) Novel treatment
GB8926171D0 (en) Treatment of infertility
GB8921818D0 (en) Treatment of carbohydrates
ZA909314B (en) Treatment of hsv
GB8916394D0 (en) Method of treatment
GB8903284D0 (en) Treatment of materials
GB2236539B (en) Treatment of spirits
ZA898265B (en) Deur-en/of vensterraamstelsel
ZA909799B (en) Bruting of gem-stones
GB8924840D0 (en) Treatment of aids
IE893589L (en) Treatment of myelosuppression
GB8922062D0 (en) Treatment of hair
IE893961L (en) Reduction of piperidine-diones
GB8925965D0 (en) Novel treatment
GB8921026D0 (en) Novel treatment
GB8921030D0 (en) Novel treatment
GB8907781D0 (en) Novel treatment
GB8907760D0 (en) Novel treatment
GB8928163D0 (en) Novel treatment
GB8926235D0 (en) Novel treatment
GB8910090D0 (en) Novel treatment
GB8921028D0 (en) Novel treatment